These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 473414

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Prolonged prostaglandin E-1 therapy of newborn infants with congenital heart defects].
    Kertész E, Hencz P, Tekulics P, Beviz J, Száva J, Matkó I, Kovács G.
    Orv Hetil; 1980 May 18; 121(20):1197-9. PubMed ID: 7413203
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Morphologic features of the ductus arteriosus after prostaglandin E1 administration for ductus-dependent congenital heart defects.
    Park IS, Nihill MR, Titus JL.
    J Am Coll Cardiol; 1983 Feb 18; 1(2 Pt 1):471-5. PubMed ID: 6681824
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comments on the pharmacologic manipulation of the ductus arteriosus in newborns.
    Rowe RD.
    Adv Prostaglandin Thromboxane Res; 1978 Feb 18; 4():383-5. PubMed ID: 645513
    [No Abstract] [Full Text] [Related]

  • 11. [Skeletal side effects of treatment with prostaglandin E1].
    Persigehl M, Hövels-Gürich H, von Bernuth G.
    Rofo; 1984 Oct 18; 141(4):427-30. PubMed ID: 6436918
    [Abstract] [Full Text] [Related]

  • 12. The ductus arteriosus: why and how to manipulate its patency.
    Drummond WH, Bucciarelli RL, Gessner IH.
    J Fla Med Assoc; 1983 Sep 18; 70(9):788-93. PubMed ID: 6355376
    [No Abstract] [Full Text] [Related]

  • 13. Use of prostaglandins in cardiopulmonary diseases of the newborn.
    Olley PM, Coceani F.
    Semin Perinatol; 1980 Apr 18; 4(2):135-41. PubMed ID: 6990504
    [No Abstract] [Full Text] [Related]

  • 14. Modified Blalock-Taussig shunt following long-term administration of prostaglandin E1 for ductus-dependent neonates with cyanotic congenital heart disease.
    Yokota M, Muraoka R, Aoshima M, Nomoto S, Shiraishi Y, Kyoku I, Kitano M, Shimada I, Nakano H, Ueda K.
    J Thorac Cardiovasc Surg; 1985 Sep 18; 90(3):399-403. PubMed ID: 4033176
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular therapy in the newborn.
    Sandor GG.
    Clin Invest Med; 1985 Sep 18; 8(4):360-7. PubMed ID: 3907921
    [Abstract] [Full Text] [Related]

  • 16. [Use of prostaglandin E1 in ductus-dependent congenital cardiopathies].
    Marcial MB, Maluf M, Atik E, Vargas H, Baucia JA, Verginelli G.
    Arq Bras Cardiol; 1983 Jun 18; 40(6):383-6. PubMed ID: 6686760
    [No Abstract] [Full Text] [Related]

  • 17. [Prostaglandin E1 in newborn infants with ductus-dependent heart diseases. Review of 40 cases].
    Simões LC, Sarachaga IH, Quero M, Casanova M, Cazzaniga M, Villibre D.
    Arq Bras Cardiol; 1985 Jul 18; 45(1):31-6. PubMed ID: 3938651
    [No Abstract] [Full Text] [Related]

  • 18. [Prostaglandins E1 in the treatment of neonatal cardiopathies related to ductus arteriosus. 19 cases].
    Maesen Y, Bosi G, Stijns M, Vliers A.
    Arch Mal Coeur Vaiss; 1981 May 18; 74(5):579-85. PubMed ID: 6794479
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prostaglandin E1 in neonates with critical congenital heart disease.
    Dungan WT, Norton JB, Readinger RI, Sotomora RF.
    J Ark Med Soc; 1982 Oct 18; 79(5):167-70. PubMed ID: 6183249
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.